chrisvoncsefalvay/vaers-outcomes huggingface dataset:
General sickness, Pain in Deltoid muscle and Shoulder joint, Painful to lift arm, physical weakness. To date (12/8/2015) painful to lift left arm, arm weakness and general weakness.
Lightheadedness, difficulty taking deep breath. Gave BENADRYL 50 mg & checked blood pressure. After about 15 minutes patient felt better & declined for us to call EMT. Patient walked around store & left without our advice.
Temp 102, scattered papules in different stages. Dx: Chickenpox post vaccination. Tx: Zovirax 800 mg 1 PO qid x 5 days.
pt recv vax 19MAY97 & devel t101.5, sore throat, rash, coung on 24MAY97;ER visit for IV fluids;
approx 4hr p/vax pt became lethargic, slurred speech, pupils dilated but not fixed;strange affect
The vial was initially stored in refrigerator on 22-Mar-2023 and was administered to patient on 24-Apr-2023; No adverse event; 75-year-old patient received Expired 5th dose Moderna COVID-19 Bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (75-year-old patient received Expired 5th dose Moderna COVID-19 Bivalent vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 22-Mar-2023 and was administered to patient on 24-Apr-2023) and NO ADVERSE EVENT (No adverse event) in a 75-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 045H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 24-Apr-2023, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 24-Apr-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (75-year-old patient received Expired 5th dose Moderna COVID-19 Bivalent vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 22-Mar-2023 and was administered to patient on 24-Apr-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (75-year-old patient received Expired 5th dose Moderna COVID-19 Bivalent vaccine), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 22-Mar-2023 and was administered to patient on 24-Apr-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (75-year-old patient received Expired 5th dose Moderna COVID-19 Bivalent vaccine) and PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 22-Mar-2023 and was administered to patient on 24-Apr-2023).    Dosage text for suspect product was reported as additional booster.  Concomitant drugs were not reported.  It was reported that the vial in carton of size 2.5 ml was not exposed to temperature excursion. It was also reported that there were three vials in carton and discarded all 3 but used 1 vial for 1 patient.  Treatment medications were not provided.
patient felt like it was heavy to breathe, dizzy. Didn't feel normal. VS BP 122/78 P 110 o2sat100.  Gave her water and told to wait 30 more min.  VS again were BP 127/74 P 90 o2sat 100. She felt fine to leave on her own
I waited the allotted 15 minutes with no change in condition. I proceeded to drive home and during the drive (15 min to my home) I began sensing something in my throat requiring me to repeatedly try to clear my throat.  By the time I arrived at my home (30 min after injection), I had chest ashiness and tightness, a sense of a lump in my throat, laryngitis and difficulty talking as result,  and dizziness, I called Employee Health Vaccine RN who directed me to go to the ER.  I arrived to the ER by 0845 and was triaged in.  I continued to have the listed symptoms.  I was treated with and EKG, vitals assessment, IV Pepcid and IV Benadryl with slow but full relief of symptoms.  I was monitored at the ER until roughly 1:00pm and then released.  I did follow up with my PCP at 2:30pm that same day.  I also did require oral Benadryl 25 mg 3 more times over the next 24 hrs due to return of chest tightness.  each time relieved by the Benadryl.   The next morning I had a full flare of my RA symptoms with severe joint pain of most joints and unable to walk due to pain.  Over the next 48 hrs I also developed fever 102 orally, swelling of upper right arm and deltoid muscle pain, nausea, and headache.
Pt vaccinated with DTP/OPV no acute rx reported by mother 48 hrs post immunization
Patient developed headaches and fever after 24 hours of receiving meningococcal vaccine.  I took her to the doctor on 2/16/07.  today is monday 2/19/07. She still has Fever and she is congested. We have gave her motrin for the fever.  But the fever comes back. 100.3F.on monday 2/19/07. time 06:30pm. I call the doctor.  She denies that the fever is a side effect from the vaccine.The doctor Suggests to take her to the ER depto. Or come back and see her the next day.
Fast heartbeat; Had a Lot's of gas & burping back to back; Had a Lot's of gas & burping back to back; Joint pain; Muscle pain; Low fever; Headache; Tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 13Sep2021 at 10:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and it was reported that the patient was vegan and mostly used plant-based medications/natural remedies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received Pfizer vaccine (details unspecified) within four weeks prior to the vaccination. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN) and inhalers (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient previously took ibuprofen (MANUFACTURER UNKNOWN), amoxicillin (AMOXI) and ibuprofen (MOTRIN) and experienced drug allergy. On an unknown date in Sep2021 the patient experienced besides Joint pain, muscle pain, low fever, fast heartbeat, headache and tiredness. The patient had a lot's of gas and burping back to back that decreased in 2 days. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events Joint pain, muscle pain, low fever, fast heartbeat, headache, tiredness and had a lot's of gas and burping back to back were resolving at the time of the report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recv vax; pink maculopapular rash on cheeks, forearms & inject site;sx occurred 4 hr p/ vax; slightly raised rash; persisted for 2 days;
Anaphylaxis - day of vaccine Welts, itching, pain, some difficulty breathing - day 8-10 after vaccine
Information has been received from a registered nurse concerning a female (age not reported) who on an unspecified date was vaccinated with Gardasil. Concomitant medication was not reported. Subsequently on an unspecified date, the patient experienced transverse myelitis which required hospitalization. Unspecified medical attention was sought. The outcome of the event was not reported. Additional information has been requested.
A week and 1 day later of the vaccination March 21, 2021 my left arm begin to itch and was very hot to the touch in the area of the vaccination, i got a rash around the area of the vaccination. On Monday March 22 Went to other sites to ask what can i do about it and if that was common, they told me to take Benadryl. It fade away a little but Today March 30, 2021 the site still a rash visible, the skin is in different color and itch some times.
2:00 PM Fever 99.2 7:00PM - 2:00AM - Cold sweating 4/25/17: cold sweating on and off during day and night.
Chills, sore throat, muscle aches, joint aches, nausea, and headache from vaccine.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of Covid-19; (Oct2023) Negative; (19Oct2023) Positive, notes: Tested negative and then after 2 days started having symptoms and tested positive again. Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient received Paxlovid from 08Oct2023 to 13Oct2023 for Treatment of COVID-19.   The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
FELT INCOHERENT; SHINGLES RASH; COLLAPSED DUE TO DIZZINESS, COULDN'T STAY UP; BODY ACHE; SORE THROAT; MUSCLE ACHE; FATIGUE; HEADACHE; This spontaneous report received from a patient concerned an 86 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included steroid allergy, shellfish allergy, and allergic to x ray dyes. The patient received JNJ78436735 (Ad26.COV2.S) (suspension for injection, route of admin not reported, batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 09:30 to left deltoid for prophylactic vaccination. No concomitant medications were reported. On 13-MAR-2021, the patient experienced fatigue and headache. On 14-MAR-2021, the patient experienced body ache, sore throat, muscle ache and collapsed due to dizziness as couldn't stay up. On 16-MAR-2021, the patient experienced shingles rash. On an unspecified date, the patient felt incoherent. The action taken with JNJ78436735 (Ad26.COV2.S) was not applicable. The patient had not recovered from fatigue, sore throat, headache, muscle ache, shingles rash, collapsed due to dizziness, couldn't stay up, and body ache whereas the outcome of felt incoherent was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: 20210332591-Covid-19 Vaccine AD26.COV2.S-collapsed due to dizziness, couldn't stay up. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
her blood pressure has fluctuated, and was recently 155/102; severe headache; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE FLUCTUATION (her blood pressure has fluctuated, and was recently 155/102) and HEADACHE (severe headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030H21B, 047B21A and 036A21A) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy. Concurrent medical conditions included Hypertension (patient has a 30 year history of hypertension but no heart disease.) and Immunocompromised. Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HCTZ) for Blood pressure, POTASSIUM CHLORIDE (K-TAB), ATENOLOL, MAGNESIUM OXIDE (MAGOX) and FOLIC ACID for an unknown indication.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In January 2022, the patient experienced BLOOD PRESSURE FLUCTUATION (her blood pressure has fluctuated, and was recently 155/102) and HEADACHE (severe headache). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, BLOOD PRESSURE FLUCTUATION (her blood pressure has fluctuated, and was recently 155/102) and HEADACHE (severe headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2022, Blood pressure measurement: 155/102 (High) blood pressure has fluctuated, and was recently 155/102.         It was reported that over the last 4 days she has had a severe headache, her blood pressure has fluctuated, and was recently 155/102.    Patient took Tylenol as needed which has helped but has not make it go away totally  the patient fluctuations had stopped after stopping the chemotherapy but came back after getting the 3rd dose.   This case was linked to MOD-2022-451598 (Patient Link).
I noticed the pain progressively, about a month after the vaccine. After a month, I went to see my doctor. I had pain in my knees, and ankles, and the plants of my feet. The doctor referred me to a podiatrist. The doctor ordered x-ray of my knees and feet. The results were normal. I took acetaminophen. I got an appointment to see the podiatrist in 6/2021. The podiatrist injected cortisone in the plants of my foot. He prescribed Diclofenac. It did not help. He also prescribed Medrol. The doctor ordered a CT scan of my feet. The doctor diagnosed me with plantar fasciitis. Till this day the plants of my feet still hurt. My knees do not hurt anymore.
Immediately following HPV9 & Meningococcal Vaccine patient loss of consciousness, her entire body stiffened and started making jerking motions, her jaw was clamped tight, and her lips looked blueish in color and she didn't appear to be breathing. The entire episode lasted less than a minute. The doctor was called in to evaluate her and shortly after appeared to be fine.
Left arm, red, hot, swollen from 1" above elbow to shoulder arm measured right arm 7" Left arm 2", Left arm rock hard, Mom denies infection. No temp 97.5. Pt does not complain about pain. Color of fingers, pink. Denies lack sensations. Instructed to use intermittent ice, Tylenol and Benadryl. If continues or worsens needs to be seen by Dr.
pt recv vax & became persistent w/acute exacerbations; pt exp congestion, cough, phlegm, & wheezing;
The patient fainted  and noted pale face immediately after injection.   He was positioned supine on the floor and applied cold towel on the forehead . The vitals were stable and was alert and oriented during this incident.  He recovered and able to walk without a problem after 15 minutes. He was observed additional 15 minutes sitting in chair and left the clinic in stable condition.
Pt seen for RUE with edema sl. induration and tenderness localized to R deltoid area 7 hrs post receiving Pneumococcal vaccine. No SOB, wheezing.
pt recv first vax in 1995; after recv dose 2, pt exp sz which were controlled with valproic acid. sx continue
About 4.5 months past my 2nd Pfizer dose, I developed new or increased intolerance to all legumes. 15-30 minutes after eating legumes (especially chickpea, soy, and pea), I get diarrhea. I have had to eliminate legumes from my diet.
This spontaneous report was received from a doctor of pharmacy referring to a 50 year old male patient. The patient did not have any pertinent medical history, concurrent condition, drug reactions or allergies. On 03-OCT-2016, the patient was subcutaneously vaccinated with an unknown dose number of ZOSTAVAX lot # L046897, expiration date 23-FEB-2017, 0.65 ml. The patient was not taking any concomitant medication. On an unspecified date in October 2016, the patient experienced headache, injection site pain and peripheral swelling. It was unknown if the patient received any treatment or if laboratory diagnostics studies were performed. The outcome of peripheral swelling, injection site pain and headache was unknown. The causal relationship between ZOSTAVAX and adverse events were not reported. Additional information has been requested.
heart attack while training; Initial information received on 27-Jan-2022 regarding an unsolicited valid  serious case received from a consumer/non-hcp.  This case involves a 53 years old and unknown gender patient who had heart attack while training after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date the patient had a heart attack while training (myocardial infarction) (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  Action taken  was not applicable.  It was not reported if the patient received a corrective treatment for the event (heart attack while training).  At time of reporting, the outcome was Unknown for the event heart attack while training.; Sender's Comments: Sanofi Company Comment dated 03-Jan-2022: This case involves a 53 years old and unknown gender patient who had heart attack while training while receiving vaccine INFLUENZA VACCINE. Based on limited information provided regarding this case, causal role of the company suspect product cannot be excluded. However, lack of information of date of vaccination, event onset date, outcome, corrective treatment, past and concomitant medication, any concurrent conditions precludes comprehensive case assessment.
Information has been received from a nurse concerning a 13 year old female who on 21-FEB-2008 was vaccinated with the second dose of VARIVAX, 0.5 ml subcutaneously (SC) (Lot #659351/1775U). On 26-FEB-2008, the patient presented with a red indurated reaction at the injection site and also the upper area of the arm. There were no vesicles present. The patient recovered on an unspecified date. The consumer contacted the physician. Follow up information was from a registered pharmacist reported that the patient with seasonal allergies who was vaccinated with a booster dose of VARIVAX, 0.5 "mg" subcutaneously (SC) (Lot #659351/1775U, expire date 06-NOV-2009). "7 days later", on 28-FEB-2008 (previously reported at 26-FEB-2008) the patient experienced swelling and redness at injection site. No therapy was given. On 02-MAR-2008, the patient recovered. Additional information is not expected.
Upper respiratory infection with high fever stared 10/27/12 Taken to doctor 11/1/12, was sent home.  Returned to doctor 11/2/12 for a second opinion. Chest xray was completed 11/2/12 Diagnosed with Pneumonitis Treated with Zithromax Fully recovered
Client became nauseous, clammy.  BP was rising.  Approx 11:30AM hives appeared on neck and top of chest.  Epinephrine given at 11:32 AM.  EMS arrived and client transported to hospital.
Approximately 7-8 minutes after receiving the vaccine, started to feel light-headed, thought she was going to pass out, and her heart was racing extremely high. The health care team at the site took her blood pressure, measured heart rate, gave her water, juice and chocolate and tried to get her heart rate to drop. It was fluctuating up and down and she couldn't stand up without dizziness;  we waited 45 minutes and then drove her home as she was unable to drive her own car.  She was experiencing significant lightheadedness, and consistent heart racing even while lying down on the sofa/bed. This continued for several days and she stayed home from school and sports. We called her primary care doctor on the 10th and they suggested she wait another day to see how she was feeling. She started to feel a bit better by Friday, was still experiencing a bit of the tiredness, nauseous, light-headed and heart spikes, but was able to drive, move around.  On Sunday evening, she started to experience increased heart rate again, lymph nodes were very painful and started experiencing the light headedness all evening.  On Monday we took her to her primary care provider and they then referred her to ER for the heart racing and a EKG. The increased light headedness, feeling like she will pass out even while laying in bed, dizziness has all increased and her lymph nodes continue to be swollen and painful. It has been over a week since the vaccine and there is no clear sign of her reaction getting any better, if not worse.  The EKG results indicated a new abnormality and we are trying to get her to a cardiologist.  She is and had been a very healthy, varsity athlete that runs over 30 hours a week with track, and since receiving the first dose of the Moderna vaccine is unable to move very far within the house without feeling that she is going to pass out or that her heart rate is shooting up uncontrollably.
Vaccine was administered too high in the shoulder joint. After an hour, the patient was unable to move her arm and sought medical attention at an urgent care.
Seriousness criteria: Important Medical Event. Initial unsolicited report received from a consumer on 30-Aug-2017. This case involves a male patient of unknown age who was vaccinated with a booster dose of DTAP (batch number, expiry date, route and site of administration was not reported), on an unknown date. The patient's medical history and concomitant medications were not reported. On an unknown date, following the vaccination, the patient developed whooping cough. The patient's laboratory data and corrective treatment were not reported. The event outcome was not reported. Upon internal review the case was considered as serious because of important medical event: whooping cough. List of documents held by sender: none. Sender's Comments: The patient experienced whooping cough post vaccination with DTAP (MFR UNK). Time to onset was not reported. No information regarding patient's medical condition at the time of vaccination or medical history was reported. No PCR test results were provided to confirm the diagnosis. Additional information regarding the same and vaccine manufacturer and latency would be required to assess the case. Based upon reported information the role of the vaccine cannot be assessed.
Local reaction to left deltoid developed 1 day after immunization administered. Swelling, induration, then localized papular erythematous rash contained to deltoid area developed 2 days after immunization.
Vomiting after my booster; This spontaneous case was reported by a pharmacist and describes the occurrence of VOMITING (Vomiting after my booster) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (Vomiting after my booster). At the time of the report, VOMITING (Vomiting after my booster) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported   This case was linked to MOD-2021-390747 (Patient Link).